Vimarsana.com
Latest Breaking News On - Academy member dr - Page 1 : vimarsana.com
The First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint
/PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing...
China
Shanghai
Oslo
Norway
Peking
Beijing
Chinese
Linda-wu
Jinghe-lang
Academy-member-dr
Expert-committee-of-colposcopy
Asieris-pharmaceuticals-stock-code
Photocure Partner Asieris announces that the First Non-Vaccine Investigational Product for Cervical HSIL has Achieved It
OSLO, Norway, Sept. 20, 2023 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces...
China
Oslo
Norway
Peking
Beijing
Chinese
Ceophotocure-asaemail
Jinghe-lang
Relationsphotocure-asatel
Linda-wu
Dan-schneiderpresident
Prnewswire-photocure
vimarsana © 2020. All Rights Reserved.